Wilmington Savings Fund Society’s AbbVie ABBV Stock Holding History

Wilmington Savings Fund Society’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Sell	51,835 -1,860	-3%	-$400K	0.29%	70
2026 Q1	$11.7M	Buy	53,695 +1,535	+3%	+$341K	0.28%	86
2025 Q4	$11.9M	Buy	52,160 +440	+0.9%	+$100K	0.28%	82
2025 Q3	$12M	Sell	51,720 -26,080	-34%	-$5.31M	0.29%	77
2025 Q2	$14.4M	Sell	77,800 -5,387	-6%	-$1M	0.26%	77
2025 Q1	$17.4M	Sell	83,187 -6,003	-7%	-$1.17M	0.33%	64
2024 Q4	$15.8M	Buy	89,190 +6,967	+8%	+$1.28M	0.29%	72
2024 Q3	$16.2M	Buy	82,223 +50,231	+157%	+$9.37M	0.29%	72
2024 Q2	$5.49M	Sell	31,992 -1,067	-3%	-$177K	0.21%	105
2024 Q1	$6.02M	Buy	+33,059	New	+$5.7M	0.23%	102
2023 Q3	$5.21M	Sell	34,983 -592	-2%	-$86.9K	0.23%	103
2023 Q2	$4.79M	Buy	35,575 +741	+2%	+$109K	0.2%	113
2023 Q1	$5.55M	Sell	34,834 -514	-1%	-$78.6K	0.25%	104
2022 Q4	$5.71M	Sell	35,348 -1,218	-3%	-$187K	0.26%	96
2022 Q3	$4.91M	Buy	36,566 +533	+1%	+$76.5K	0.24%	103
2022 Q2	$5.52M	Sell	36,033 -1,945	-5%	-$297K	0.25%	103
2022 Q1	$6.16M	Sell	37,978 -221	-0.6%	-$32.1K	0.24%	101
2021 Q4	$5.17M	Sell	38,199 -1,171	-3%	-$138K	0.19%	119
2021 Q3	$4.25M	Sell	39,370 -451	-1%	-$51.5K	0.16%	123
2021 Q2	$4.49M	Buy	39,821 +1,612	+4%	+$182K	0.17%	122
2021 Q1	$4.13M	Sell	38,209 -1,019	-3%	-$109K	0.17%	126
2020 Q4	$4.2M	Sell	39,228 -1,191	-3%	-$114K	0.18%	119
2020 Q3	$3.54M	Sell	40,419 -1,300	-3%	-$122K	0.16%	128
2020 Q2	$4.1M	Sell	41,719 -714	-2%	-$62.9K	0.2%	119
2020 Q1	$3.23M	Buy	42,433 +3,303	+8%	+$281K	0.19%	120
2019 Q4	$3.46M	Sell	39,130 -3,372	-8%	-$280K	0.18%	125
2019 Q3	$3.22M	Buy	42,502 +588	+1%	+$40.3K	0.18%	129
2019 Q2	$3.05M	Sell	41,914 -2,334	-5%	-$183K	0.16%	135
2019 Q1	$3.57M	Buy	44,248 +4,816	+12%	+$394K	0.19%	126
2018 Q4	$3.64M	Buy	39,432 +1,114	+3%	+$98K	0.22%	123
2018 Q3	$3.62M	Sell	38,318 -552	-1%	-$52.3K	0.19%	134
2018 Q2	$3.6M	Sell	38,870 -211	-0.5%	-$20.6K	0.2%	134
2018 Q1	$3.7M	Sell	39,081 -323	-0.8%	-$35.5K	0.21%	133
2017 Q4	$3.81M	Sell	39,404 -1,348	-3%	-$127K	0.21%	132
2017 Q3	$3.62M	Sell	40,752 -843	-2%	-$64.2K	0.21%	137
2017 Q2	$3.02M	Buy	41,595 +2,844	+7%	+$191K	0.18%	149
2017 Q1	$2.52M	Sell	38,751 -4,786	-11%	-$301K	0.15%	153
2016 Q4	$2.73M	Sell	43,537 -1,592	-4%	-$97.2K	0.17%	149
2016 Q3	$2.85M	Buy	45,129 +400	+0.9%	+$25.9K	0.18%	146
2016 Q2	$2.77M	Sell	44,729 -2,264	-5%	-$138K	0.18%	144
2016 Q1	$2.68M	Sell	46,993 -555	-1%	-$30.9K	0.17%	148
2015 Q4	$2.82M	Sell	47,548 -764	-2%	-$44K	0.18%	142
2015 Q3	$2.63M	Sell	48,312 -618	-1%	-$40.2K	0.17%	145
2015 Q2	$3.29M	Sell	48,930 -1,513	-3%	-$98.8K	0.19%	140
2015 Q1	$2.95M	Sell	50,443 -1,258	-2%	-$76K	0.17%	149
2014 Q4	$3.38M	Sell	51,701 -2,342	-4%	-$148K	0.19%	141
2014 Q3	$3.12M	Sell	54,043 -4,039	-7%	-$224K	0.18%	146
2014 Q2	$3.28M	Sell	58,082 -702	-1%	-$36.8K	0.18%	149
2014 Q1	$3.02M	Sell	58,784 -6,373	-10%	-$322K	0.17%	156
2013 Q4	$3.44M	Sell	65,157 -15,259	-19%	-$750K	0.19%	141
2013 Q3	$3.6M	Sell	80,416 -15,518	-16%	-$688K	0.22%	126
2013 Q2	$3.97M	Buy	+95,934	New	+$4.2M	0.26%	109

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wilmington Savings Fund Society's ABBV Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its AbbVie (ABBV) stake by 3.5% in Q2 2026, selling an estimated $400K and leaving 51,835 shares worth $13M. The position accounts for 0.29% of the portfolio, ranked #70.

Wilmington Savings Fund Society first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.4M in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wilmington Savings Fund Society held 51,835 shares of AbbVie worth $13M as of Q2 2026.
Wilmington Savings Fund Society sold 1,860 AbbVie shares in Q2 2026, an estimated $400K.
AbbVie made up 0.29% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #70 holding.
Wilmington Savings Fund Society first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Wilmington Savings Fund Society's AbbVie position peaked at $17.4M in Q1 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.